Literature DB >> 6486199

A screening protocol for a prenatal population at risk for inherited hemoglobin disorders: results of its application to a group of Southeast Asians and blacks.

J Stein, C Berg, J A Jones, J C Detter.   

Abstract

Several inherited hemoglobin disorders are present among certain racial subgroups of the United States population, particularly among blacks and Southeast Asians. Many of these disorders are unfamiliar to the obstetrician-gynecologist but may have important implications for care in pregnancy, including genetic counseling and prenatal diagnosis. A simple, effective screening tool was devised for detection of thalassemias and hemoglobinopathies in a prenatal clinic population. Use of the tool resulted in diagnosis of a hemoglobin disorder in 20% of a group of black patients; diagnoses included alpha-thalassemia trait, beta-thalassemia trait, hemoglobin C trait, hemoglobin S/C disease, hemoglobin S trait, sickle cell anemia, and hemoglobin Lepore. In a group of Southeast Asian patients, 39% had a hemoglobin disorder, including alpha-thalassemia trait, beta-thalassemia trait, hemoglobin E disease, and hemoglobin H disease. Implications for care are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6486199     DOI: 10.1016/s0002-9378(84)80134-9

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Maternal morbidity and perinatal outcomes among foreign-born Cambodian, Laotian, and Vietnamese Americans in Washington State, 1993-2006.

Authors:  Swee May Cripe; William O'Brien; Bizu Gelaye; Michelle A Williams
Journal:  J Immigr Minor Health       Date:  2011-06

2.  Delayed bottle weaning and iron deficiency in southeast Asian toddlers.

Authors:  E A Graham; T H Carlson; K K Sodergren; J C Detter; R F Labbe
Journal:  West J Med       Date:  1997-07

3.  Pregnancy characteristics and outcomes of Cambodian refugees.

Authors:  P Gann; L Nghiem; S Warner
Journal:  Am J Public Health       Date:  1989-09       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.